MF. Sowers, J. L. Beebe, D. McConnell, John Randolph, and M. Jannausch

Similar documents
Hormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index

SAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:

Obesity and Breast Cancer Risk

A Tale of Three Hormones: hcg, Progesterone and AMH

WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH

PERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.

Therapeutic Cohort Results

Reproductive physiology

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies

One Day Hormone Check

ADRENOCORTEX STRESS PROFILE

Disclosures. Nutrition & Menopause. What changes? Mindless Eating 10/6/2017. I have no disclosures

ROKSANA KARIM, MBBS, PHD UNIVERSITY OF SOUTHERN CALIFORNIA LOS ANGELES, CA

ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)

Relationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women

Estrogens and progestogens

The study of correlation between BMI and infertility. Dr. seyed mohammadreza fouladi

Polycystic Ovary Syndrome

Risk Factors for Breast Cancer

Does Hysterectomy Lead to Weight Gain or Does Overweight Lead to Hysterectomy?

Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women s Health Initiative Observational Study

International Cartilage Repair Society

WEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY

Therapeutic Cohort Results

Therapeutic Cohort Results

Labrix Clinical Services, Inc.

Dietary soy intake and changes of mammographic density in premenopausal Chinese women

One Day Hormone Check

Adrenal Stress Profile (Saliva)

Metabolic changes in menopausal transition

Consideration of Anthropometric Measures in Cancer. S. Lani Park April 24, 2009

BIOSYNTHESIS OF STEROID HORMONES

Breast Cancer and Bone Loss. One in seven women will develop breast cancer during a lifetime

Fruit and vegetable consumption in adolescence and early adulthood and risk of breast cancer: population based cohort study

Reproductive. Estradiol Analyte Information

TESTOSTERONE AND CARDIOVASCULAR RISK IN MEN 685

INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview

The Association between Sleep Duration, Insomnia and Weight Change in the Women s Health Initiative Observational Study

ComprehensivePLUS Hormone Profile with hgh

Hormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, PHYSICAL HEALTH, AND LIFESTYLE IN OLDER ADULTS

Breast Cancer Risk in Patients Using Hormonal Contraception

Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study

Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018

Achieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center

Infertility: A Generalist s Perspective

CASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?

Su Yon Jung 1*, Eric M. Sobel 2, Jeanette C. Papp 2 and Zuo-Feng Zhang 3

MEASURE. MANAGE. MOTIVATE. bodyandbone MOBILE LAB DEXA BODY COMPOSITION SCAN RESTING METABOLIC RATE TEST DEXA BONE MINERAL DENSITY TEST

Downloaded from:

Action of reproductive hormones through the life span 9/22/99

Medical risk reducing strategies for breast cancer

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Mitochondrial DNA Haplogroups and Breast Cancer Risk Factors in the Avon Longitudinal Study of Parents and Children (ALSPAC)

The menstrual Cycle. François Pralong

METABOLIC SYNDROME IN REPRODUCTIVE FEMALES

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?

Conjugated Linoleic Acid Technical Document Feb Conjugated Linoleic Acid

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan

RELATIONSHIP BETWEEN BMI, TOTAL TESTOSTERONE, SEX HORMONE-BINDING-GLOBULIN, LEPTIN, INSULIN AND INSULIN RESISTANCE IN OBESE MEN

The menstrual cycle. François Pralong

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

Bone Mineral Density and Its Associated Factors in Naresuan University Staff

Polycystic Ovarian Syndrome (PCOS) LOGO

Relationship Between Caffeine Intake and Plasma Sex Hormone Concentrations in Premenopausal and Postmenopausal Women

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

What Is Body Composition?

Sex Steroid Levels and Response to Weight Loss Interventions among Postmenopausal Women in the Diabetes Prevention Program

Energy Balance and Macronutrient Distribution in Relation to CRP and HbA1c Levels Among Patients with Type 2 Diabetes

Suprailiac or Abdominal Skinfold Thickness Measured with a Skinfold Caliper as a Predictor of Body Density in Japanese Adults

Leptin Concentrations in Women in the San Antonio Heart Study: Effect of Menopausal Status and Postmenopausal Hormone Replacement Therapy

Hormone Treatments and the Risk of Breast Cancer

DIABETES, PHYSICAL ACTIVITY AND ENDOMETRIAL CANCER. Emilie Friberg

Obesity and Breast Cancer Risk in Hispanics: Findings from the Breast Cancer Health Disparities Study

Reproductive outcome in women with body weight disturbances

Understanding Body Composition

METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY

University of Medicine and Pharmacy Craiova. Faculty of Medicine. PhD THESIS ABSTRACT

Hormonal Control of Human Reproduction

GONADAL FUNCTION: An Overview

Estrogens vs Testosterone for cardiovascular health and longevity

UGRC 145: FOOD AND NUTRITION IN EVERYDAY LIFE

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

Relationship between Energy Expenditure Related Factors and Oxidative Stress in Follicular Fluid

Determinants of Obesity-related Underreporting of Energy Intake

HEALTHY AGING AND THE ENDOCRINE ENVIRONMENT: THE ASSOCIATION BETWEEN THE ENDOCRINE ENVIRONMENT AND BODY COMPOSITION IN POSTMENOPAUSAL WOMEN

Gonadotrophin treatment in patients with Polycystic Ovary Syndrome

Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE

Nitasha Garg 1 Harkiran Kaur Khaira. About the Author

Why Do We Treat Obesity? Organ-Specific, Hormonal, and Biomechanical Complications

Picking the Perfect Pill How to Effectively Choose an Oral Contraceptive

The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome

An Evidence-based Review of Clinical Trial Data

Female Sexual Hormones Indications and Therapy

Case Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation

Abnormal Uterine Bleeding Case Studies

Abdul R. Khan, MD LABORATORY DIRECTOR S. Pioneer Blvd Artesia, CA Tel: Fax: LABORATORY REPORT

A Canonical Correlation Analysis of Physical Activity Parameters and Body Composition Measures in College Students

Premature Menopause : Diagnosis and Management

Transcription:

American Journal of Epidemiology Copyright 200 by The Johns Hopkins University School of Hygiene and Public Health All rights reserved Vol. 53, No. 3 Printed in U.S.A. Testosterone Concentrations in Women Sowers et al. Testosterone Concentrations in Women Aged 25 50 Years: Associations with Lifestyle, Body Composition, and Ovarian Status MF. Sowers, J. L. Beebe, D. McConnell, John Randolph, and M. Jannausch While there is substantial evidence of the importance of endogenous and exogenous estrogen in reproductive health and chronic disease, there is little consideration of androgens in women s health. In the Michigan Bone Health Study (992 995), the authors examined the correlates of testosterone concentrations in pre- and perimenopausal women (i.e., age, menopausal status, body composition, and lifestyle behaviors) in a population-based longitudinal study including three annual examinations among 6 women aged 25 50 years identified through a census in a midwestern community. Current smokers had the highest testosterone concentrations with decreasing values in former and nonsmokers (p = 0.000). Body composition measures (body mass index, body fat (%), weight (kg), lean body mass (kg), and fat mass (kg)) were significantly and positively associated with total testosterone concentrations in a dose-response manner. Hysterectomy with oophorectomy was associated with significantly lower testosterone concentrations. Alcohol consumption, physical activity, and dietary macronutrient intake were not associated with testosterone concentrations. This is one of the first studies to examine correlates of serum testosterone concentrations in anticipation of the growing interest in the role of androgens in women s health. The greater circulating levels of testosterone in obese women and smokers suggest that testosterone concentrations should be considered in the natural history of disease conditions where obesity and smoking are risk factors, including cardiovascular disease. Am J Epidemiol 200;53:256 64. alcohol drinking; body composition; body mass index; hysterectomy; ovariectomy; smoking; testosterone Estrogens and their effect on reproductive health and chronic diseases, including cardiovascular disease and cancers, particularly breast cancer, have been the overwhelming focus of hormone studies in women (). In contrast, there is relatively little information about the role of androgens in women s health. However, testosterone products are being increasingly promoted to women in the lay press as a means of increasing well-being. Testosterone is the most important circulating and naturally occurring androgen in both men and women. In women, testosterone is produced primarily through peripheral conversion of androstenedione (50 percent) with the remainder of production concentrated in the ovary (25 percent) and adrenal cortex (25 percent) (2). During pregnancy, the placenta may also serve as a source of the hormone (3). In women, abnormally high levels of testosterone have been associated with hirsutism and polycystic ovary syndrome (2). Hirsutism is a consequence of increased Received for publication July 26,999, and accepted for publication March 3, 2000. Abbreviations: DEXA, dual energy x-ray absorptiometry; MET, metabolic equivalent. From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI. Correspondence to Dr. MF. Sowers, Department of Epidemiology, School of Public Health, University of Michigan, 08 S. Observatory Street, Ann Arbor, MI 4809-2029 (e-mail: mfsowers@umich.edu). production of testosterone or testosterone precursors (dehydroepiandrosterone, 3α-androstanediol, or androst-4- ene-3,7-dione (3)) and depression of sex hormone binding globulin (2). Circulating levels of free to total testosterone in hirsute women are double those of nonhirsute women (2). Polycystic ovary syndrome is related to ovulatory dysfunction and is a common cause of female infertility (2). Testosterone concentrations have been evaluated for their associations with chronic diseases. Serum levels of testosterone have been suspected in the etiology of breast cancer of postmenopausal women. Zeleniuch-Jacquotte et al. (4) reported an increased risk of breast cancer with increasing concentrations of serum total testosterone (unadjusted p for trend < 0.05). However, this trend was no longer significant after adjustment for total estradiol concentrations and the percent of sex hormone binding globulin-bound estradiol. Nonetheless, those authors speculated that testosterone or its metabolites might still play a role in breast cancer etiology by altering the availability of estrogens, by competitively binding with sex hormone binding globulin, and/or by acting as an estrogen precursor. Likewise, androgen concentrations have been associated with insulin levels and diabetes mellitus (5). However, a temporal sequence between higher levels of androgen and increased insulin levels has not been firmly established, as higher androgen concentrations may result in increased insulin resistance or increased insulin production may stimulate androgen production in the ovary (6). Sowers et al. (7) have reported an association of Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 256

Testosterone Concentrations in Women 257 osteoarthritis and serum testosterone concentrations in women aged 25 45 years. Numerous studies have examined factors that influence testosterone concentrations in men, and these may provide an indication of the factors that influence or are associated with testosterone concentrations in women. In men, older age has been consistently associated with declining levels of testosterone (8, 9). Lower testosterone concentrations were associated with increased body mass (8). Smoking was also associated with increased concentrations of serum testosterone in men, whereas alcohol consumption and moderate physical activity do not appear to be associated with variation in testosterone concentrations (8, 0). Using testosterone concentrations measured at three consecutive annual examinations in a longitudinal study, we describe the factors that are associated with those testosterone levels in pre- and perimenopausal Caucasian women. The study examined total serum testosterone concentrations in relation to the following: ) lifestyle variables, including smoking behavior, alcohol consumption, dietary intake, and amount of physical activity; 2) changes in ovarian function, specifically exogenous hormone use and hysterectomy; 3) age, and 4) body composition and body topology. This is one of the few papers to describe correlates of testosterone concentrations in a population-based study of women and the only one that focuses largely on pre- and perimenopausal women. MATERIALS AND METHODS Study population The measures used in this study were collected as part of the longitudinal Michigan Bone Health Study (). Briefly, in 988, 542 premenopausal Caucasian women, aged 20 40 years, were recruited for participation. These women represented more than 80 percent of the age-eligible female offspring listed in the family records of the Tecumseh, Michigan, Community Health Study (959 972). Ageeligible women whose parents had not been participants of the original Tecumseh Community Health Study were added in 992. There were 35 female residents who were contacted using a population-based sampling frame (Kohl s directory) that included age, name, address, and telephone number, and of these, 22 were enrolled. A total of 664 women (aged 25 45 years) were eligible for participation in the subsequent examinations that began in 992 993. Participation varied according to pregnancy status, willingness to participate in any given year, and availability to participate in the examination time window. There were 589 women (89 percent) in the first examination, 575 women (87 percent) in the second examination, and 542 women (82 percent) in the third examination. There were 5 women (77 percent) participating in all three rounds, and 85 percent (56 women) provided data from at least two examinations. Measurements Testosterone levels. Women were evaluated annually on the anniversary of their initial assessment (± month). At Am J Epidemiol Vol. 53, No. 3, 200 each examination, blood was drawn in days 3 7 of the follicular phase of the menstrual cycle and after an 8-hour fast. For women not normally menstruating within 3 months of the examination, blood was drawn after fasting and indexed to the anniversary date of their first annual examination. Serum was frozen at 80 C. Total testosterone was assessed with a solid-phase 25 I radioimmunoassay based on a testosterone-specific antibody immobilized to the wall of a polypropylene tube. The assay precision was ±5.5 percent. Behavioral characteristics. The annual examinations included the administration of health questionnaires. Smoking status was based on questionnaires and women were categorized as never, former, or current smokers. The participants were classified by their self-reported consumption of alcohol as ) nondrinkers, 2) currently consuming 0 g (less than one drink) per week, 3) currently consuming 0 7 g per week, and 4) currently consuming >7 g (more than two drinks) per week. Groups 2, 3, and 4 are the first, second, and third tertiles, respectively, among those who report consuming alcohol at least once a week. Annually, women reported physical activity during the previous week, previous July, and previous December. These data were averaged, and an algorithm modeled on the Stanford Five City instrument was used to indicate average weekly activity in metabolic equivalents (METs) (2). One MET is the energy consumed per minute of sitting at rest. METs per week were divided into tertiles of <3, 3 344, and >344. Anthropometric measures. Height (cm) and weight (kg) were measured using a stadiometer and balance-beam scale, and body mass index was calculated as weight (kg)/height (m) 2. The waist/hip ratio was calculated using hip and waist circumference measures (cm). Body composition (body fat (percent), lean and fat mass (kg)) was determined using dual energy x-ray absorptiometry (DEXA) (Lunar Corporation, Madison, Wisconsin). The DEXA instrumentation uses a constant potential (76 kv(p) x-ray tube with K-edge filtration (350 mg/cm 2 )) with effective beam energies at 38 and 70 kv. Scanning speed was selected for the anterior-posterior abdominal thickness of the woman being evaluated. Reproductive measures. Women were classified as never, former, or current users of hormone replacement therapy and oral contraceptives, based on self-report. Current use was confirmed with interviewer observation of container labels. Women were also identified as having a hysterectomy with and without double oophorectomy and confirmed by medical record. Nutritional measures. Daily macronutrient intake was estimated from the 98-item Health Habits and History Questionnaire (3). The food frequency portion of the Health Habits and History Questionnaire estimates usual past year nutrient intake from the recall of the frequency of consumption of particular food items and portion size. Data analysis All statistical procedures in this analysis were performed using SAS software version 6.2 (SAS Institute, Cary, North Carolina). Univariate statistics were calculated for continu- Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204

258 Sowers et al. ous variables, and frequency statistics were calculated for categorical variables. Testosterone concentrations were analyzed using a square root transformation, but the data presented in tables through 4 have been untransformed to facilitate recognition of the units. However, the beta coefficients and standard errors in the longitudinal models (table 5) remain in their transformed state because of the complexity of the standard error measure. Analysis of variance was used in comparing the mean testosterone levels and standard errors for groups at the first, second, and third examinations. The comparison groups for the cross-sectional evaluations of the data were defined by lifestyle factors and reproductive status. Regression models were used to identify those variables independently associated with testosterone concentrations from among the significant associations in the bivariate analysis. Longitudinal mixed models were used to evaluate possible time trends and the influence of the time-varying variables (measures of body composition and ovarian status) with respect to testosterone concentrations over the 3-year period (Proc Mixed; SAS Institute). The random intercept and random slope, plus measurement error, were used to model the variability in the correlated measurements. Only those variables identified as consistently important in the cross-sectional analyses were entered into the longitudinal analyses, and then those variables that were no longer significant in an overall model were removed (i.e., lean mass), and a final longitudinal model was identified. Because there was concern that the population might include women with undiagnosed polycystic ovary syndrome, we withdrew from analysis the data of women who were at the 95th percentile or greater of the body mass index and reran our final model to ensure that the same variables retained their importance. A similar process was also used for the data of women who were at the 95th percentile or greater of the baseline testosterone distribution. RESULTS The characteristics of participants are shown in table. Among the participants, the average age was 38 years, and the age range was 27 47 years at the last examination. Older age (within this cohort of relatively younger women) was not an important explanatory variable. Significant increases in percent body fat, weight, and body mass index were observed among study subjects over the 3-year period (test for trend, p < 0.05). The mean amount of alcohol consumed increased somewhat, although, overall, the amounts reported were quite low. The proportion of the population that reported current smoking behavior TABLE. Characteristics of the participants of the Michigan Bone Health Study reported from each of the three consecutive annual examinations Characteristic 992 993 993 994 994 995 Total testosterone (pg/ml) Mean (SD*) Median (25th 75th percentiles) Range Body composition (mean (SD)) Weight (kg) Height (cm) BMI* (kg/m 2 ) Fat mass (kg) Lean mass (kg) % body fat Alcohol (g/day) Physical activity (METs*/week) Smoking (no. (%)) Never Former Current Oral contraceptive use (no. (%)) Never Former Current Hormone replacement therapy (no. (%)) Never Former Current Hysterectomy (no. (%)) With oophorectomy Without oophorectomy 209 (20.6) 99 (3 299) 432 7.6 (6.9) 63.4 (5.9) 26.8 (6.2) 28.6 (2.5) 39.2 () 40.6 (8.8).0 (2.4) 337 (47) 377 (66) 67 (2) 27 (22) 332 (57) 6 (28) 85 (5) 540 (93) 6 () 37 (6) 35 (6) 29 (5) 20 (9.2) 209 (35 297) 473 7.9 (6.6) 63.4 (5.9) 26.9 (6.0) 29.6 (2.4) 38.8 () 4.6 (8.7). (2.5) 333 (4) 369 (66) 78 (4) 5 (20) 333 (59) 87 (33) 48 (8) 525 (92) 0 (2) 33 (6) 33 (6) 3 (5) 223 (20.7) 22 (42 32) 557 72.7 (7.6) 63.3 (5.9) 27.2 (6.4) 30.0 (2.9) 39. () (9.0).3 (2.5) 339 (42) 356 (67) 76 (4) 03 (9) 309 (57) 8 (33) 5 (0) 483 (89) 0 (2) 48 (9) 35 (7) 33 (6) Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 * SD, standard deviation; BMI, body mass index; METs, metabolic equivalents. Among women who report drinking alcohol. Am J Epidemiol Vol. 53, No. 3, 200

Testosterone Concentrations in Women 259 decreased slightly. The mean level of physical activity remained constant. The prevalence of hysterectomy was percent. Lifestyle variables and testosterone concentrations Smoking behavior was associated with increased serum testosterone levels. Women who reported that they were currently smoking had significantly higher testosterone concentrations when compared with women who did not currently smoke (table 2, p < 0.000). The pattern among current, former, and nonsmokers was consistent at each examination. Current smokers had the highest mean levels, with mean total testosterone concentrations decreasing in former and nonsmokers. Self-reported alcohol consumption was not associated with total testosterone concentrations cross-sectionally. The mean testosterone levels did not differ significantly between drinkers and nondrinkers with the exception of the 994-995 examination. However, when the analysis was then restricted to only those individuals participating in all years of the study, differences in concentrations in the third examination were no longer statistically significant. Physical activity was not associated with testosterone concentrations in any of the 3 years of examination (table 2). Women in the upper tertile of the physical activity distribution had testosterone concentrations similar to those in women in the lowest tertile of physical activity crosssectionally and across time. The grams of protein, fat, or carbohydrate intake, as well as total energy intake (calories), were not associated with total testosterone concentrations (data not shown). Reproductive status Women using oral contraceptives and women using hormone replacement therapy had significantly lower testosterone concentrations than did women who were nonusers (table 3). Whereas women with oophorectomy had significantly lower testosterone concentrations than did premenopausal women, women with hysterectomy and ovarian conservation had testosterone concentrations that were not significantly different from those of premenopausal women. Body composition Increasing weight was associated with increasing total testosterone concentration at every examination (table 4). Women in the highest body mass index category (>30 kg/m 2 ) had testosterone concentrations that were 50 70 pg/ml higher than did women in the lowest category ( 22 kg/m 2 ). Measures of body composition were consistently TABLE 2. Mean total testosterone concentrations (pg/ml) in relation to age and self-reported lifestyle behaviors including smoking practice, alcohol consumption, and amount of physical activity as measured from serum collected at three consecutive annual examinations, Michigan Bone Health Study Age 34 years >34 to 38 years >38 to 4 years >4 years 992 993 993 994 994 995 Mean SD* Mean SD Mean SD 224 25 97 20 * SD, standard deviation; METs, metabolic equivalents. p value testing from analysis of variance on transformed data that were then untransformed. 4.4 26 29 208 203 4.6 4.0 232 242 200 26 p value 0.28 0.70 0.07 Smoking status Never Former Current 96 27 267 2.5 6.6 5.9 93 224 27 2.5 6.3 6.3 222 249 289 p value <0.0 <0.0 <0.0 Alcohol consumption Nondrinkers drink/week > to 2 drinks/week >2 drinks/week 26 22 206 207 20 2 27 4.4 220 208 209 245 p value 0.92 0.9 0.09 Physical activity 3 METs*/week >3 to 344 METs/week >344 METs/week 208 22 23 25 23 226 220 98 p value 0.9 0.74 0.89 6.0 5.2 2.9 7. 7.2 4. 5.0 4. Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 Am J Epidemiol Vol. 53, No. 3, 200

260 Sowers et al. TABLE 3. Mean total testosterone concentrations (pg/ml) associated with selected reproductive characteristics, from serum collected at three consecutive annual examinations, Michigan Bone Health Study 992 993 993 994 994 995 Mean SD* Mean SD Mean SD Oral contraceptives Current users Nonusers 53 22 associated with testosterone concentrations in a doseresponse relation. The amount of fat mass explained more variation in total testosterone than did lean body mass, although both were significantly associated with testosterone concentrations. Increased percent body fat, assessed with DEXA, was associated with higher levels of testosterone. The relation persisted following adjustment for smoking. There were no significant interactions between smoking and any of the anthropometric measures in relation to testosterone concentrations. A greater waist circumference was associated with higher testosterone concentrations cross-sectionally. Women with a waist circumference of 87 cm had testosterone concentrations that were 50 70 pg/ml higher than the mean concentrations in women with waist circumferences of <70 cm. Whereas there appeared to be a trend of increasing total testosterone with increasing waist/hip ratio, this association was not statistically significant across all examinations. Independent contributors to testosterone concentrations 2.5 39 28 * SD, standard deviation. p value testing from analysis of variance on transformed data that were then untransformed. Cross-sectional regression models considered smoking, hormone use, oophorectomy, fat mass, lean body mass, and waist circumference simultaneously. The correlations between smoking, fat mass, hormone use, and oophorectomy and total testosterone remained statistically significant, while lean body mass and waist circumference were no longer significantly correlated. We also evaluated the association of testosterone concentrations over time in longitudinal models considering body composition, smoking behavior, hormone use, and reproductive surgery status (table 5). Smoking behavior and increasing body mass index were each associated with increasing testosterone concentrations over time, whereas hysterectomy with oophorectomy was associated with a decline in testosterone concentrations over time. These relations were consistent whether the entire population was considered (table 5, panel A) or whether the women with the highest 5 percent of body composition were excluded from analysis (table 5, panel B). Likewise, the same variables remained important when the data from women with the highest 5 percent of testosterone concentration (table 5, panel C) were excluded in the event that they might have undiagnosed polycystic ovary syndrome. DISCUSSION 5. 2.4 75 227 p value <0.0 <0.0 <0.0 Hormone replacement therapy Current users Nonusers 63 24 6.8 77 23 7.7 7 227 p value 0.02 0. <0.0 Hysterectomy with ovary conservation Yes No 240 2 0.9 235 23 0.5 2.4 266 224 p value 0.4 0.34 0.09 Double oophorectomy Yes No 85 24 7.9 59 25 6.9 52 226 p value 0.20 <0.0 <0.0 6.3 2.6 6.2 2.6.4 2.6 6.5 2.5 In this population-based study, smoking behavior and measures of body composition were associated with increased serum testosterone concentrations. There were no significant associations with other lifestyle variables representing alcohol consumption, physical activity, and intake of energy and the macronutrients, protein, carbohydrate, and fat. Smoking was associated with increased serum testosterone concentrations and after adjustment for other factors, including body mass index. Of the few studies that have previously examined smoking and androgen levels in women, the findings are highly inconsistent. Longcope and Johnston (4) measured the metabolic clearance rates and production rates of estrogen and androgens in smokers and nonsmokers as part of an ongoing study of hormones and osteoporosis in Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 Am J Epidemiol Vol. 53, No. 3, 200

Testosterone Concentrations in Women 26 TABLE 4. Mean total testosterone concentrations (pg/ml) in association with measures of body composition and body topology (waist/hip ratio), from serum collected at three consecutive annual examinations, Michigan Bone Health Study 992 993 993 994 994 995 Mean SD* Mean SD Mean SD Weight (kg) 60 >60 to 68 >68 to 80 >80 79 88 228 254 78 99 226 242 4.4 4.6 5.0 92 203 234 258 p value <0.0 <0.0 <0.0 Body mass index (kg/m 2 ) 22 >22 to 26 >26 to 30 >30 74 93 222 262 5.5 70 92 244 242 96 200 246 246 p value <0.0 <0.0 <0.0 % body fat 34 >34 to 42 >42 to 48 >48 70 92 226 268 4.8 5.9 74 2 248 4. 4. 5. 20 23 247 p value <0.0 <0.0 <0.0 Fat mass (kg) 20 >20 to 27 >27 to 37 >37,750 82 232 269 3.4 6.0 76 20 223 246 4.6 95 20 233 257 p value <0.0 <0.0 <0.0 Lean body mass (kg) 35 >35 to 39 >39 to 42 >42 86 20 20 234 97 203 243 4. 95 23 224 255 p value 0.03 0.02 <0.0 Waist/hip ratio 0.73 >0.73 to 0.76 >0.76 to 0.80 >0.80 90 99 220 239 5. 2 200 227 29 206 28 235 24 p value 0.02 0.20 0.09 Waist circumference (cm) 70 >70 to 78 >78 to 87 >87 76 95 227 26 5.7 74 209 223 246 4.0 5.0 95 208 247 244 p value <0.0 <0.0 <0.0 * SD, standard deviation. p value testing from analysis of variance on transformed data that were then untransformed. Determined using dual energy x-ray absorptiometry instrumentation. 4. 5. 4. 5.5 5. 4.8 5. 4.6 5.5 5.2 7.7 4.0 5.7 5.2 Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 88 pre- and postmenopausal women. They found that the metabolic clearance rates for smokers were lower for androstenedione, testosterone, estrone, and estradiol when compared with those of nonsmokers. However, following adjustment for weight, these differences disappeared with the exception of androstenedione. Khaw et al. (5) examined the relation between smoking and endogenous sex hormone levels in 233 White, postmenopausal women aged 60 79 years. Current cigarette use was positively associated with concentrations of the adrenal androgens, dehydroepiandrosterone sulfate, and androstenedione. However, mean concentrations of estrone, estradiol, sex hormone Am J Epidemiol Vol. 53, No. 3, 200

262 Sowers et al. TABLE 5. Longitudinal models of testosterone concentrations (pg/ml) considering all participants (panel A), participants less than the 95th percentile of body mass index (panel B), and participants less than the 95th percentile of testosterone (panel C), Michigan Bone Health Study Random intercept Participation year 992 993 993 994 994 995 Baseline smoking No Yes Body mass index (kg/m 2 ) Reproductive status No surgery Hysterectomy only Hysterectomy and double oophorectomy All participants (panel A) SE* (β) binding globulin, and testosterone did not differ significantly between smokers and nonsmokers. Thomas et al. (6) compared estradiol, as well as androgen and salivary progesterone, concentrations in 25 normal premenopausal smokers and 2 nonsmokers measured in a single menstrual cycle. They found no significant differences in plasma testosterone, androstenedione, and dehydroepiandrosterone concentrations. A possible explanation for the inconsistency between our findings and those of other studies is the choice of populations to study. The Michigan Bone Health Study subjects are largely premenopausal while the other studies focused primarily on postmenopausal women or a combination of preand postmenopausal participants. In premenopausal women, testosterone is produced in the ovaries and adrenals, while in postmenopausal women, testosterone is produced by the adrenals and the peripheral conversion of androstenedione in adipose tissue. We speculate that the greater concentrations of testosterone observed among current smokers were more likely a product of decreased metabolism rather than increased biosynthesis of the hormone. Longcope and Johnston (4) provide evidence to support this theory. Cytochrome P-450 hydroxylases are responsible for the oxidative metabolism of steroid hormones in general. These enzymes mediate the introduction of an oxygen atom (derived from water or molecular oxygen) into the steroid nucleus. P-450 hydroxylases are subject to inhibition by carbon monoxide. Smokers have greater circulating carbon monoxide concentrations as a byproduct of tobacco smoke. This may inhibit P-450 hydroxylases and explain the increased concentrations of testosterone and its precursors. Thus, future studies of androgen and smoking in women need to consider products in the androgen pathway as well as the availability of bioactive β 0 2 2 p value <0.0 0.94 0. <0.0 <0.0 0.2 <0.0 * SE, standard error. p value for individual level of fixed effect. Based on square-root transform (i.e., if transformed, β = 9.86 is 97.23). Referent group. <95th percentile body mass index (panel B) β SE (β) p value 9 <0.0 2 2 0.53 0.04 <0.0 <0.0 0. <0.0 testosterone, concentrations of sex hormone binding globulin, and receptor binding. Alcohol consumption was not associated with testosterone concentrations in this study, and findings are inconsistent in other studies. For example, Cigolini et al. (7) observed that daily alcohol intake was positively and independently correlated with plasma-free and total testosterone in 87 light-tomoderate drinking premenopausal women, while Gavaler and VanThiel (8) identified increased metabolism of testosterone. One likely explanation for the contrast in findings may be related to the amount and frequency of alcohol consumption. Eighty percent of our population reported drinking drink per week, while other study populations consumed alcohol daily or in much larger quantities (4 5 drinks per week). Testosterone concentrations did not change with the level of physical activity in our study participants, but most studies that have examined the relation between testosterone and physical activity in women have focused on female athletes or on acute changes in testosterone following heavy exercise (9 2). Reproductive factors <95th percentile testosterone (panel C) β SE (β) p value 0 <0.0 We found that users of oral contraceptives and hormone replacement therapy had significantly lower testosterone concentrations when compared with nonusers, although hormone use was not included in the longitudinal summary models, because women with hysterectomy/oophorectomy were more likely to be using hormones leading to colinearity in the models. Our findings are consistent with those of other studies that have examined exogenous hormone use and androgen levels (22 25). Study participants with hysterectomy/oophorectomy had significantly lower testosterone levels when compared with 2 2 0.08 <0.0 <0.0 <0.0 0.09 <0.0 Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 Am J Epidemiol Vol. 53, No. 3, 200

Testosterone Concentrations in Women 263 women who had neither procedure. Few studies have examined the relation between hysterectomy and testosterone levels, and none have made the distinction between hysterectomy with and without bilateral oophorectomy. There are two general metabolic pathways by which testosterone is produced, one via the ovary and the other via the adrenals. In the follicular tissue of the ovary and the adrenal cortex, the 4 and 5 pathways produce testosterone from progesterone and pregnenolone. Pregnenolone appears to be a more efficient precursor of testosterone than progesterone in ovaries without corpus luteum. Women with oophorectomy have decreased levels of testosterone because production relies primarily on the adrenal cortex and peripheral conversion of androstenedione (3). In a recent paper (26), it was argued that lower testosterone levels in women with hysterectomy are a key risk factor for cardiovascular risk and that removal of the uterus compromises the function of the ovaries even when they are spared (26, p. 829). In our study, hysterectomy with ovarian conservation was associated with significantly higher testosterone concentrations when compared with those of other participants. Body composition and body topology variables Body mass index, waist/hip ratio, and percent body fat were all positively associated with testosterone concentrations. Of the studies that have focused on the anthropometric predictors of androgen concentrations in women, one found a positive relation (27) and two found no relation after adjustment for other factors (7, 28). Increases in lean body mass were also reported to be associated with higher testosterone levels in a previous paper from this study (29). It has long been appreciated that a subset of women with significantly higher androgen concentrations was more likely to be obese. Androgen metabolism is accelerated in obese individuals and is associated with lower sex hormone binding globulin levels, but it is not known whether increased clearance precedes or follows accelerated production of androgen (30). We evaluated whether the observed association of body composition measures and testosterone concentrations was being unduly influenced by a small group of women with hyperandrogenism (and its accompanying obesity). We reconstructed the data set to remove the contribution of those women whose total testosterone level was in the top 5 percent of the androgen distribution. Even in their absence, we still observed significant associations with body composition and smoking behavior. Likewise, because polycystic ovary syndrome is associated with obesity, we reconstructed the data set to remove the contribution of those women in the top 5 percent of the body mass index distribution. The same variables remained statistically important. This suggests that the findings of smoking, body composition, and reproductive status are not the reflection of undue influence by a subgroup of women in the population with subclinical or undiagnosed polycystic ovary syndrome. This is one of the first papers to describe the correlates of testosterone concentrations in women and the only one that focuses largely on pre- and perimenopausal women. However, the measures are of total testosterone rather than Am J Epidemiol Vol. 53, No. 3, 200 free, bioavailable testosterone. In addition, there are other limitations in our study design. Although our sample size was large enough to detect significant differences in mean testosterone in most situations, we were unable to contrast differences between postmenopausal women and the other groups because of the small number of postmenopausal participants. In addition, a 3-year follow-up of these individuals is insufficient to assess changes in testosterone over time and with age. In summary, past research efforts have focused primarily on the relation between estrogen and disease in women and have largely ignored testosterone in relation to health and disease states in women with the exception of a few disorders. The greater circulating levels of testosterone with obese women and smokers suggest that testosterone may be an important contribution to those disease conditions where obesity and smoking are risk factors, including cardiovascular disease. ACKNOWLEDGMENTS This research was funded by grant AR R0-40888 from the National Institutes of Health, National Institute of Arthritis, Musculoskeletal, and Skin Diseases. The authors thank Mary Crutchfield of the Michigan Bone Health Study and Dr. Stanley Korneman for their respective contributions. REFERENCES. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 997;8:7 06. 2. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore, MD: Williams and Wilkins, 994:457 55. 3. Norman AW, Litwack G. Hormones. 2nd ed. San Diego, CA: Academic Press, 997:9 86. 4. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JMG, et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 997;45:030 8. 5. Andersson B, Marin P, Lissner L, et al. Testosterone concentrations in women and men with NIDDM. Diabetes Care 994; 7:405. 6. Haffner SM. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm Res 996;45:233 7. 7. Sowers MF, Hochberg M, Crabbe JP, et al. Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. Am J Epidemiol 996;43:38 47. 8. Ben-Aryeth H, Abu-Nassar A, Laufer D, et al. Salivary testosterone levels in men and women: changes with age and correlation with plasma testosterone. Isr J Med Sci 989;25:344 6. 9. Dai WS, Kuller LH, LaPorte RE, et al. The epidemiology of plasma testosterone levels in middle-aged men. Am J Epidemiol 98;4:804 6. 0. Zmuda JM, Cauley JA, Kriska A, et al. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men: a 3-year follow-up of former Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204

264 Sowers et al. Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 997;46:609 7.. Sowers MF, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre- and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res 998;3:34 40. 2. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 985;2:9 06. 3. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 986;24:453 69. 4. Longcope C, Johnston CC Jr. Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers. J Clin Endocrinol Metab 988;67: 379 83. 5. Khaw KT, Tazuke S, Barrett-Conner E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 988;38:705 9. 6. Thomas EJ, Edridge W, Weddell A, et al. The impact of cigarette smoking on the plasma concentrations of gondaotrophins, ovarian steroids and androgens and upon the metabolism of oestrogens in the human female. Hum Reprod 993;8:87 93. 7. Cigolini M, Targher G, Bergamo-Andreis IA, et al. Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women. Int J Obes Relat Metab Disord 996;20:206 2. 8. Gavaler JS, VanThiel DH. The association between moderate alcohol beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature. Alcohol Clin Exp Res 992;6:87 92. 9. Tsai L, Johansson C, Pousette A, et al. Cortisol and androgen concentrations in female and male elite endurance athletes in relation to physical activity. Eur J Appl Physiol 99;63: 308. 20. Cumming DC, Wall SR, Quinney HA, et al. Decrease in serum testosterone levels with maximal intensity swimming exercise in trained male and female swimmers. Endocr Res 987;3: 3 4. 2. Keizer H, Janssen GM, Menheere P, et al. Changes in basal plasma testosterone, cortisol, and dehydroepiandrosterone sulfate in previously untrained males and females preparing for a marathon. Int J Sports Med 989;0(suppl):S39 45. 22. Moutos D, Smith S, Zacur H. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotrophins, androgens and sex hormone binding globulin: a randomized trial. Contraception 995;52:05 9. 23. Coenen CM, Thomas CM, Borm GF, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 996;53:7 6. 24. Kuhnz W, Staks T, Jutting G. Pharmacokinetics of levonorgestrel and ethinyl estradiol in 4 women during three months of treatment with a tri-step combination oral contraceptive; serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum. Contraception 994;50:563 79. 25. Tazuke S, Khaw KT, Barrett-Conner E, et al. Exogenous estrogen and endogenous sex hormones. Medicine (Baltimore) 992;7:44 5. 26. Rako S. Testosterone deficiency: a key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging? J Womens Health 998;7:825 9. 27. Cauley JA, Gutai JP, Kuller KH, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 989;29:20 3. 28. Goodman-Gruen D, Barrett-Connor E. Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women. Int J Obes Relat Metab Disord 995;9: 293 8. 29. Sowers MF, Crutchfield M, Jannausch ML, et al. Longitudinal changes in women approaching the midlife. Ann Hum Biol 996;23:253 65. 30. Conway GS. Polycystic ovary syndrome: clinical aspects. Baillieres Clin Endocrinol Metab 996;0:263 79. Downloaded from http://aje.oxfordjournals.org/ at Pennsylvania State University on March 4, 204 Am J Epidemiol Vol. 53, No. 3, 200